tirzepatide for diabetes FDA approves tirzepatide, Eli Lilly's new type 2 drug, and the company shares an estimated price NICE recommends Lilly's tirzepatide for

Investigation into GLP-1-based diabetes therapies concluded

In addition, recent studies indicate that some drugs routinely used in the treatment of allergies (H1 receptor antagonists) have additional anti-glycooxidant and anti-inflammatory effects, which may offset allergy complications caused by oxidative and carbonyl stress (270)

They work by slowing digestion, signaling fullness to the brain, and reducing hunger cues

The FDA has been increasingly vocal about concerns

Other GLP-1 medications like liraglutide and tirzepatide are only available as injectables, though research into oral formulations of various GLP-1 medications continues